Loss of RAGE in pulmonary fibrosis: molecular relations to functional changes in pulmonary cell types

Area of Science:

• Pulmonary Medicine
• Cell Biology
• Immunology

Background:

• Receptor for advanced glycation end products (RAGE) is an Ig superfamily transmembrane receptor.
• While RAGE expression is linked to kidney and liver fibrosis, it's highly expressed in healthy lungs.
• Idiopathic pulmonary fibrosis (IPF) involves complex cellular and molecular changes in the lung.

Purpose of the Study:

• To assess RAGE expression in IPF.
• To investigate RAGE's role in the functional changes of lung epithelial cells and fibroblasts in IPF pathogenesis.

Main Methods:

• Quantitative assessment of RAGE expression using RT-PCR, Western blotting, and immunohistochemistry in IPF patient lung tissue and bleomycin-induced mouse lung fibrosis models.
• In vitro studies using primary human lung fibroblasts and A549 epithelial cells stimulated with TGF-β1 or TNF-α to induce RAGE down-regulation.
• Functional assays including cell adhesion, proliferation, and migration after RAGE blockade or knockdown using small interfering RNA (siRNA).

Main Results:

• Significant down-regulation of RAGE was observed in lung homogenates and alveolar epithelial type II cells from IPF patients and in bleomycin-treated mice.
• Pro-inflammatory cytokines (TGF-β1, TNF-α) induced RAGE down-regulation in human lung fibroblasts and A549 cells in vitro.
• RAGE blockade impaired cell adhesion, while RAGE knockdown increased proliferation and migration of lung epithelial and fibroblast cells.

Conclusions:

• RAGE plays a protective role in the lung.
• Down-regulation of RAGE in IPF is associated with altered lung cell function.
• Loss of RAGE contributes to the pathogenesis and fibrotic consequences observed in idiopathic pulmonary fibrosis.